Skip to main content
. 2019 Feb 14;20(4):821. doi: 10.3390/ijms20040821
APO Apolipoprotein
AQP2 Aquaporin-2
BCAAs Branched chain amino acids
BCG Bacillus Calmette Guérin
BLCA Bladder carcinoma
BTA Bladder tumor antigen
CCL18 C-C motif chemokine 18
CDK1 Cycline-dependent kinase 1
CXCR2 Chemokine receptor 2
CYFRA Cytokeratin 19 fragment
DNA Deoxyribonucleic acid
EDIL3 EGF-like repeat and discoindin I-like domain-containing protein 3
EGFR Epidermal growth factor receptor
ELISA Enzyme-linked immunosorbent assay
EPS8L Epidermal growth factor receptor kinase substrate 8-like protein
EVs Extracellular vesicles
FDA Food and Drug Administration
FGFR3 Fibroblast growth factor receptor
FISH Fluorescent in situ hybridization
H2B1K Histone cluster 1 H2B family member K
HOTAIR HOX transcript antisense RNA
HOXA13 Homeobox A13
HOX-AS-2 HOXA cluster antisense RNA 2
IGFBP5 Insulin-like growth factor-binding protein 5
ISEV International Society for Extracellular Vesicles
LC Liquid chromatography
MALAT-1 Metastasis-associated lung adenocarcinoma transcript 1
MALDI Matrix-assisted laser desorption/ionization
MDK Midkine
MS Mass spectrometry
MVBs Multivesicular bodies
(N)MIBC (Non-)muscle invasive bladder cancer
NMPs Nuclear matrix proteins
PAI-1 Plasminogen activator inhibitor 1
PON2 Paraoxonase-2
ProEGF Epidermal growth factor
RNA Ribonucleic acid
SAA4 Serum amyloid A4
SNPs Single nucleotide polymorphisms
TACSTD2 Tumor-associated calcium-signal transducer 2
Tregs Regulatory T cells
UBC Urinary bladder cancer antigen
UC Ultracentrifugation